Using TMS to Improve Cognitive Function in Alzheimers Disease

Watching someone lose their memory in small increments is different from reading about Alzheimer's disease in textbooks. Families notice when a parent forgets the grandchildren's names or can't follow a conversation they would have managed easily six months ago. The brain changes that cause these losses have been studied for decades, but slowing cognitive decline remains difficult, and that's partly why researchers keep looking at different approaches that might help preserve function for longer.

One area getting attention lately involves transcranial magnetic stimulation, or TMS, which was originally developed for psychiatric conditions but is now being tested in neurodegenerative disease. The basic idea is that targeted magnetic pulses might stimulate brain regions involved in memory and thinking, though how much this actually helps in Alzheimer's is still being worked out. It's not a cure, and it probably won't reverse damage that's already occurred, but some early studies suggest it might slow certain types of decline in specific patients.

What Transcranial Magnetic Stimulation Actually Does

Transcranial magnetic stimulation uses a magnetic coil placed against the scalp to create small electrical currents in targeted brain areas. The pulses can temporarily increase or decrease activity in those regions, depending on the frequency used, and over time this appears to influence how neurons communicate with each other. It's a noninvasive procedure, meaning nothing enters the brain or body, which is one reason it's considered relatively safe compared to surgical interventions.

The technique has been used for years in TMS for depression, where it targets the prefrontal cortex to help regulate mood circuits. That application is FDA approved and fairly well established now. The jump to Alzheimer's involves aiming those same magnetic pulses at brain regions affected by memory loss, particularly areas like the dorsolateral prefrontal cortex or the parietal regions that handle spatial processing and executive function.

Why Researchers Started Looking at TMS for Alzheimer's

Alzheimer's disease causes progressive damage to brain cells, especially in areas responsible for forming new memories and managing complex thought. Standard medications like cholinesterase inhibitors can help with symptoms for a while, but they don't stop the underlying neurodegeneration, so clinicians have been interested in anything that might preserve neural function through different mechanisms. The idea behind using transcranial magnetic stimulation is that repeated stimulation could strengthen remaining neural connections or encourage the brain to form compensatory pathways around damaged areas.

Animal studies showed that magnetic stimulation could improve markers of brain plasticity and reduce some of the protein buildup associated with Alzheimer's pathology. Human trials are less straightforward because cognitive decline varies considerably between patients, but early phase studies suggested that some people experienced modest improvements in attention, memory recall, or executive tasks after several weeks of TMS treatment. The results weren't dramatic, but they were enough to keep research going.

What the Studies Show So Far

Most of the published research involves small groups of patients, usually in mild to moderate stages of Alzheimer's, who receive daily or near daily TMS sessions for several weeks. Some studies report improvements in standardized cognitive tests, particularly in domains like working memory or processing speed, though not all participants respond. Other trials show stabilization rather than improvement, meaning cognitive scores don't decline as quickly as expected during the treatment period. That's not nothing, but it's also not the kind of recovery families hope for.

The effects tend to be temporary. When TMS treatment stops, cognitive benefits often fade over the following months, which suggests that maintenance sessions might be needed to sustain any gains. A few researchers are combining TMS with cognitive training exercises to see if the two approaches work better together, and early data looks somewhat promising. Still, we're a long way from knowing which patients benefit most, what stimulation parameters work best, or how long effects can realistically last.

How TMS Treatment Sessions Work

A typical session involves sitting in a chair while a technician positions the magnetic coil against specific points on the scalp. The coil delivers rapid pulses that create a tapping sensation and sometimes cause mild muscle twitching in the face or scalp, but most people tolerate it without much discomfort. Each session usually lasts 20 to 40 minutes, and a standard course might involve five sessions per week for four to six weeks, though protocols vary across studies and clinical settings.

Patients stay awake during treatment and can often go home immediately afterward. There's no sedation and no recovery period, so it doesn't interfere much with daily routines. Side effects are generally mild, the most common being temporary headache or scalp discomfort at the stimulation site. Seizures are a rare but serious risk, particularly in people with certain neurological conditions, which is why screening before treatment matters.

Who Might Be a Candidate

Not everyone with Alzheimer's is a good fit for transcranial magnetic stimulation. Most research protocols focus on patients in the early to moderate stages, when there's still enough functional brain tissue to respond to stimulation. People with very advanced disease, where large areas of the brain are already significantly damaged, probably won't see much benefit. Medical history also matters, anyone with metal implants in the head, a history of seizures, or certain cardiac devices may not be eligible for safety reasons.

The decision usually involves a neurologist or geriatric psychiatrist who can assess cognitive status, review imaging studies, and discuss realistic goals. TMS for Alzheimer's is still considered investigational in most settings, meaning it's often available through research trials or specialized centers rather than routine clinical practice. Insurance coverage is inconsistent, which can be a barrier for families interested in trying it.

Managing Expectations Around Results

It helps to be clear about what transcranial magnetic stimulation might and might not do. This isn't a treatment that reverses Alzheimer's or brings back lost memories. At best, it may slow the rate of decline in some cognitive domains or provide a temporary boost in mental sharpness for certain patients. The benefits are usually subtle, not the kind of dramatic improvement that families notice right away, and they require ongoing sessions to maintain.

For some people, even modest stabilization feels worthwhile, especially if it means maintaining independence a bit longer or staying engaged in conversations and activities that matter. For others, the time commitment and uncertainty around results make it less appealing. There's also the reality that TMS treatment works better for some individuals than others, and we don't yet have reliable ways to predict who will respond before starting.

What Families Should Consider

Deciding whether to pursue transcranial magnetic stimulation involves weighing potential benefits against practical realities like time, cost, and availability. Families should ask about the specific protocol being used, what the evidence shows for that approach, and what kind of monitoring will happen during and after treatment. It's reasonable to want some sense of how progress will be measured, whether through formal cognitive testing or more subjective assessments of daily function.

This also isn't an either or situation. TMS can be considered alongside standard Alzheimer's medications, cognitive therapies, and lifestyle interventions that support brain health. In practice, most clinicians see it as one possible tool in a broader management strategy, not a standalone solution. The research is still evolving, so what we know now will likely look different in five years as more data comes in and protocols get refined.